Abattis Bioceuticals Corp (ATTBF)
0.00
USD |
OTCM |
May 24, 16:00
Abattis Bioceuticals Shareholders Equity (Quarterly): 8.368M for Sept. 30, 2019
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2019 | 8.368M |
| June 30, 2019 | 9.141M |
| March 31, 2019 | 9.884M |
| December 31, 2018 | 9.662M |
| September 30, 2018 | 8.891M |
| June 30, 2018 | 52.13M |
| March 31, 2018 | 53.42M |
| December 31, 2017 | 8.886M |
| September 30, 2017 | 1.226M |
| June 30, 2017 | 1.884M |
| March 31, 2017 | 1.134M |
| December 31, 2016 | 1.094M |
| September 30, 2016 | 0.5103M |
| June 30, 2016 | 0.7512M |
| March 31, 2016 | 0.6224M |
| December 31, 2015 | 0.8221M |
| September 30, 2015 | 0.641M |
| June 30, 2015 | 2.118M |
| March 31, 2015 | 2.495M |
| December 31, 2014 | 2.935M |
| September 30, 2014 | 3.622M |
| June 30, 2014 | 4.598M |
| Date | Value |
|---|---|
| March 31, 2014 | 4.382M |
| December 31, 2013 | 0.378M |
| September 30, 2013 | 0.5409M |
| June 30, 2013 | 0.7405M |
| March 31, 2013 | 1.008M |
| December 31, 2012 | 1.112M |
| September 30, 2012 | 0.6355M |
| June 30, 2012 | 0.3156M |
| March 31, 2012 | 0.4472M |
| December 31, 2011 | 0.503M |
| September 30, 2011 | 0.5691M |
| June 30, 2011 | 0.3268M |
| March 31, 2011 | 0.3543M |
| December 31, 2010 | 0.5577M |
| September 30, 2010 | 0.3681M |
| June 30, 2010 | 0.4066M |
| December 31, 2009 | 0.539M |
| September 30, 2009 | 0.5464M |
| June 30, 2009 | -0.0651M |
| March 31, 2009 | -0.609M |
| September 30, 2008 | -0.0522M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.368M
Minimum
Sep 2019
9.141M
Maximum
Jun 2019
8.755M
Average
8.755M
Median
Shareholders Equity (Quarterly) Benchmarks
| Acasti Pharma Inc | 64.68M |
| Aurinia Pharmaceuticals Inc | 377.95M |
| Edesa Biotech Inc | 4.324M |
| Lexaria Bioscience Corp | 6.521M |
| Liminal Biosciences Inc (DELISTED) | 16.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.55M |
| Total Liabilities (Quarterly) | 6.492M |